OTCMKTS:BLOZF Cannabix Technologies (BLOZF) Stock Price, News & Analysis $0.38 -0.01 (-3.55%) As of 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlinesBuy This Stock About Cannabix Technologies Stock (OTCMKTS:BLOZF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Cannabix Technologies alerts:Sign Up Key Stats Today's Range$0.38▼$0.4050-Day Range$0.38▼$0.5752-Week Range$0.33▼$0.68Volume182,301 shsAverage Volume75,845 shsMarket Capitalization$46.68 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Cannabix Technologies Inc. is a Canada-based developer of biosensor technologies focused on the rapid, non-invasive detection of cannabis impairment. The company’s flagship product is a handheld breathalyzer device designed to identify recent use of tetrahydrocannabinol (THC) within minutes of exhalation, offering law enforcement agencies, public safety organizations and workplace safety departments a potential tool to assess impairment in real time. The Cannabix breathalyzer employs proprietary sensor arrays and on-board algorithms to distinguish THC molecules in breath samples, delivering results without the need for laboratory analysis. In addition to its cannabis detection platform, the company is exploring integration of alcohol and multi-drug screening capabilities to create a more comprehensive roadside and occupational testing solution. Cannabix has pursued partnerships with research institutions and regulatory bodies to validate its technology under controlled conditions. Headquartered in Vancouver, British Columbia, Cannabix Technologies conducts its research and development activities at its Canadian laboratories and collaborates with external contract manufacturers for product assembly. The company’s management team is led by Chief Executive Officer Craig Ellins, who brings experience in technology commercialization and regulatory affairs. The board and executive suite also include professionals with backgrounds in biosensor engineering, public safety and diagnostics marketing. As a publicly traded entity on the OTC Markets under the symbol BLOZF, Cannabix Technologies continues to advance its prototype toward regulatory approval and commercial rollout. Its primary markets include North America and select international jurisdictions considering roadside and workplace drug screening solutions, with ongoing efforts to secure government contracts and private-sector distribution agreements.AI Generated. May Contain Errors. Read More Receive BLOZF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cannabix Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BLOZF Stock News HeadlinesCannabix Technologies Announces Deployment of Marijuana Breath Test (MBT) with Major Industrial Operator in QuebecJune 15, 2026 | globenewswire.comCannabix Expands BreathLogix Alcohol Screening Technology into Mining, Municipal and Aviation Sectors in AustraliaMay 29, 2026 | globenewswire.comYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.June 24 at 1:00 AM | Profits Run (Ad)Cannabix Marijuana Breath Test Achieves Major Milestone: Breath Collection Unit Secures UL and CSA CertificationsMay 13, 2026 | globenewswire.comCannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Workplace Drug and Alcohol Testing ClinicMay 4, 2026 | globenewswire.comOmega Laboratories to Host Educational Panels and Present Cannabix Marijuana Breath Test Solution at the 2026 NDASA Conference in CaliforniaApril 20, 2026 | globenewswire.comCannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Virginia based Industrial Manufacturing ClientApril 1, 2026 | globenewswire.comCannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction ClientMarch 19, 2026 | globenewswire.comSee More Headlines BLOZF Stock Analysis - Frequently Asked Questions How have BLOZF shares performed this year? Cannabix Technologies' stock was trading at $0.4370 on January 1st, 2026. Since then, BLOZF shares have decreased by 13.0% and is now trading at $0.38. How were Cannabix Technologies' earnings last quarter? Cannabix Technologies Inc. (OTCMKTS:BLOZF) posted its earnings results on Tuesday, December, 30th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.09 million for the quarter. How do I buy shares of Cannabix Technologies? Shares of BLOZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings12/30/2025Today6/24/2026Fiscal Year End4/30/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorBusiness Services Industry Technology Services Sub-IndustryN/A Current SymbolOTCMKTS:BLOZF CIKN/A Webwww.cannabixtechnologies.com Phone604-551-7831Fax604-676-2767EmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.36 million Net MarginsN/A Pretax Margin-3,920.00% Return on Equity-300.86% Return on Assets-258.30% Debt Debt-to-Equity RatioN/A Current Ratio6.44 Quick Ratio5.99 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.02 per share Price / Book19.00Miscellaneous Outstanding Shares122,840,000Free FloatN/AMarket Cap$46.68 million OptionableNot Optionable Beta0.96 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (OTCMKTS:BLOZF) was last updated on 6/24/2026 by MarketBeat.com Staff. From Our PartnersFirm That Predicted 2008, 2020, 2022: Right Now Looks WorseThe firm that predicted the dot-com crash, the 2008 financial crisis, the 2020 COVID crash, and the 2022 bear ...TradeSmith | SponsoredThe Treasury just bought its own debtOn April 16th, the U.S. Treasury executed a $15 billion buyback of its own debt - the largest in history - whi...Golden Portfolio | SponsoredElon’s message for AmericaElon Musk bought Super Bowl ad time at $266,000 per second - something he has never done before. 125 million A...Stansberry Research | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely, LLC | SponsoredElon Is Quietly Doubling Down on This Bizarre AssetYahoo Finance reports this technology 'May Unlock $400 Trillion' - and Bloomberg calls it 'unavoidable.' Elon ...Brownstone Research | Sponsored“The unseen winner of the AI race” is not SpaceXMarc Chaikin - the analyst who called Nvidia before its historic run - says a tech firm labeled 'the unseen wi...Chaikin Analytics | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cannabix Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cannabix Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
